National Cancer Research Institute South of England
Prostate Cancer Collaborative
Core Resources

Prostate Tissue Arrays

Tissue arrays constructed by
Prof Colin Cooper csc@icr.ac.uk, A Fletcher fletcher@icr.ac.uk,
Dr A Falconer falconer@icr.ac.uk, Dr Ros Eeles ros@icr.ac.uk
Institute of Cancer Research
and Prof Chris Foster, University of Liverpool

Tissue arrays are being constructed as part of the Collaboratives’ Molecular Pathology programme. An H&E stained section of the formalin fixed tumour is first examined by a histopathologist who marks the location of the tumour and normal tissue.

To make tissue arrays a block of Lambwax is first placed in the recipient block holder in the Tissue Arrayer (Fig 1).

tissue arrayer
Fig 1

A core is taken of wax and is then removed (Fig 2a). A bridge is then placed over the recipient wax block. The block containing the formalin preserved prostate specimen together with the H&E stained section aligned on top is then placed on the bridge (Fig 2b).

 

Fig 2a taking core from recipient block

Fig 2b bridge and block and slide

Their position is then adjusted so that the coring needle is aligned with the region of the tumour to be sampled. The core is then taken (Fig 2c). Following removal of the bridge the core is then placed in the hole in the recipient block (Figure 2d). The procedure is repeated to construct the entire array. For each cancer six 0.6mm cores are taken from the formalin preserved specimens two from each of the two major areas contributing to the Gleason score and two from regions of normal tissue. Finally, sections from the tissue array are mounted on slides and used for immunohistochemical, DNA and RNA analyses.

Fig 2c taking core from block

Fig 2d placing core in recipient block

The NCRI Collaborative have currently constructed tissue arrays form 100 prostate cancers. Construction of arrays from a further 100 specimens is underway. The Core Tissue Array Facility is also being used by Professor Jack Cuzick to construct tissue arrays from 2000 prostate cancers.

The benefits of tissues arrays are numerous. They include the analysis of multiple markers over a large number of tumours in a relatively short space of time, generating large data sets very quickly. Tissue arrays are very economical, instead of hundreds of experiments on hundreds of different slides. Only a few experiments on a few slides containing arrays would be needed, reducing costs in the reagents and manual labour departments.

To use the Collaboratives’ prostate tissue array please email:- fletcher@icr.ac.uk.

Collaborative Home Page


Quick Links to other pages
grey = under construction

Aetiology and Genetics

Epidemiological Identification of Families
Genetic Susceptibility
Diet and Environment
Chemoprevention

Molecular Pathology

Links to Cancer Genome Project
Development of Normal Prostate
Microarray Expression Profiling
Candidate Genes
Novel Telomerase Suppressor Genes
Subtractive Hybridization
CESH

Novel Therapies

New Drugs for Prostate Cancer
Intensity Modulated Radiotherapy
Immunotherapy
Academic Urology Unit
Novel Targets from Cancer Genome Project
Novel Mechanism Based Drugs

Core Resources

Cancer Gene Cloning Lab
Prostate Tissue arrays
Microarray laboratory
Tissue and blood collections
Bioinformatics

Pilot and Development Funds

Tumor micro-environment in early prostate cancer

Collaborations
Meetings and Seminars

Contact us on Email: cbell@icr.ac.uk Tel: 0208 643 8901 Fax: 0208 770 7290 This page last modified: 20/02/03